Metrion Biosciences, Bioqube Ventures collaboration to identify novel ion channel inhibitors for autoimmune diseases
Metrion Biosciences, a specialist ion channel contract research and drug discovery company, and Bioqube Ventures, a specialist European life sciences investment firm, have entered into a collaboration, backed by Bioqube Factory Fund I, to incubate a drug discovery research project targeting autoimmune diseases.